Cargando…

Evaluation of nephroprotection of silymarin on contrast-induced nephropathy in liver cirrhosis patients: A population-based cohort study

Recent findings from an animal experiment suggest a modest association between silymarin and decreased risk of contrast-induced nephropathy. However, the relationship between silymarin and contrast-induced nephropathy in patients with liver cirrhosis remains unclear. From 1997 to 2007, we identified...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuo, Yu-Jui, Chang, Hui-Ping, Chang, Yu-Jun, Wu, Hsing-Hsien, Chen, Chang-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155955/ https://www.ncbi.nlm.nih.gov/pubmed/30212956 http://dx.doi.org/10.1097/MD.0000000000012243

Ejemplares similares

Silymarin and diabetic nephropathy
por: Rafieian-Kopaie, Mahmoud, et al.
Publicado: (2012)

Amiodarone and risk of liver cirrhosis: a nationwide, population-based study
por: Huang, Ching-Hui, et al.
Publicado: (2019)

Silymarin for the Prevention of Contrast-Induced Nephropathy: A Placebo-Controlled Clinical Trial
por: Sedighifard, Zohreh, et al.
Publicado: (2016)

In Vitro and In Vivo Nephroprotective Effects of Nelumbo nucifera Seedpod Extract against Cisplatin-Induced Renal Injury
por: Chen, Jui-Yi, et al.
Publicado: (2022)

Nephroprotective Effects of Synthetic Flavonoid Hidrosmin in Experimental Diabetic Nephropathy
por: Jiménez-Castilla, Luna, et al.
Publicado: (2021)

Nephroprotective effects of diacylglycerol on diabetic nephropathy in type 2 diabetic rats
por: Li, Jianpeng, et al.
Publicado: (2018)

Data on nephroprotective effect of all-trans retinoic acid in early diabetic nephropathy
por: Sierra-Mondragón, Edith, et al.
Publicado: (2018)

Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT
por: Choi, Heejung, et al.
Publicado: (2012)

Silymarin Accelerates Liver Regeneration after Partial Hepatectomy
por: Wu, Jia-Ping, et al.
Publicado: (2015)

The Survival of Septic Patients with Compensated Liver Cirrhosis Is Not Inferior to That of Septic Patients without Liver Cirrhosis: A Propensity Score Matching Analysis
por: Chang, Ya-Chun, et al.
Publicado: (2022)

Nationwide cohort study of outcomes of acute myocardial infarction in patients with liver cirrhosis: A nationwide cohort study
por: Wu, Victor Chien-Chia, et al.
Publicado: (2020)

Nephroprotective effect of Curculigo orchiodies in streptozotocin–nicotinamide induced diabetic nephropathy in wistar rats
por: Singla, Krishan, et al.
Publicado: (2020)

Nephroprotective potential of syringic acid in experimental diabetic nephropathy: Focus on oxidative stress and autophagy
por: Sherkhane, Bhoomika, et al.
Publicado: (2023)

A nephroprotective iodinated contrast agent with cardioprotective properties: A pilot study
por: Rowe, Elizabeth S., et al.
Publicado: (2021)

Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis C
por: Tang, Kuo-Tung, et al.
Publicado: (2016)

Nephroprotective Effects of L-Carnitine against Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Open-Labeled Clinical Trial
por: Mohammadi, Mohammad, et al.
Publicado: (2017)

Risk and adverse outcomes of fractures in patients with liver cirrhosis: two nationwide retrospective cohort studies
por: Chen, Ta-Liang, et al.
Publicado: (2017)

Association of prognostic nutritional index with risk of contrast induced nephropathy: A meta-analysis
por: Chang, Wei-Ting, et al.
Publicado: (2023)

A population-based cohort study of mortality of intensive care unit patients with liver cirrhosis
por: Huang, Yu-Feng, et al.
Publicado: (2020)

Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B
por: Tang, Kuo-Tung, et al.
Publicado: (2016)

Investigating the impact of silymarin on liver oxidative injury
por: Jamalian, Mohammad, et al.
Publicado: (2020)

Nephroprotective effect of Bauhinia variegata (Linn.) whole stem extract against cisplatin-induced nephropathy in rats
por: Pani, Saumya R., et al.
Publicado: (2011)

Upper Gastrointestinal Cancer and Liver Cirrhosis
por: Jeng, Kuo-Shyang, et al.
Publicado: (2022)

The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM)
por: Yang, Jai-Sing, et al.
Publicado: (2018)

Nephroprotective Properties of Antidiabetic Drugs
por: Gerdes, Christian, et al.
Publicado: (2023)

Effect of silymarin in diabetes mellitus patients with liver diseases
por: Jose, Manonmani Alvin, et al.
Publicado: (2011)

Nephroprotective Role of Zhibai Dihuang Wan in Aristolochic Acid-Intoxicated Zebrafish
por: Lu, Ping-Hsun, et al.
Publicado: (2020)

Nephroprotective Effect of Adropinin Against Streptozotocin-Induced Diabetic Nephropathy in Rats: Inflammatory Mechanism and YAP/TAZ Factor
por: Guo, Ling, et al.
Publicado: (2021)

Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C
por: Tseng, Chih-Wei, et al.
Publicado: (2016)

Association of type 2 diabetes with liver cirrhosis: a nationwide cohort study
por: Hsieh, Ping-Hsin, et al.
Publicado: (2017)

Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study
por: Kuo, Yu‐Jui, et al.
Publicado: (2019)

Silymarin’s Inhibition and Treatment Effects for Alzheimer’s Disease
por: Guo, Hong, et al.
Publicado: (2019)

Radiocontrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease
por: Jo, Sang-Kyung
Publicado: (2012)

Retracted: Silymarin Accelerates Liver Regeneration after Partial Hepatectomy
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2017)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
por: Gillessen, Anton, et al.
Publicado: (2020)

Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review
por: Tighe, Sean P., et al.
Publicado: (2020)

Protective effect of silymarin on tacrolimus-induced kidney and liver toxicity
por: Terzi, Funda, et al.
Publicado: (2022)

Protective Effect of Silymarin on Liver in Experimental in the Sepsis Model of Rats
por: Aydemir Celep, Nevra, et al.
Publicado: (2023)

Mechanisms of Herbal Nephroprotection in diabetes mellitus
por: Dragoș, Dorin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1cr9n15qkit6tj51suebkb3v2s